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Background: Candida species are opportunistic pathogens
that cause superﬁcial and systemic candidiasis particularly in
immunocompromised patients. Resistance to many clinically used
antifungal agents has created a need to identify new compounds
and develop drugs for therapeutic use. Therefore, the main objec-
tive was to carry out bioguided fractionation of the ethanolic and
aqueous extracts of the leaves, twigs, stem, stembark and trunck of
Uvariodendron calophyllum.
Methods & Materials: The leaves were macerated in ethanol
and water, their yields of extraction were calculated. The broth
micro dilution method was used for antifungal susceptibility
testing of yeasts (Candida albicans, Candida glabrata, Candida para-
psilosis, Cryptococcus neoformans isolates and four candida albicans
strainsATCCL26, ATCC 12C, ATCC P37039, ATCC P37037). Phyto-
chemical screeningon thecrudeextractswasdone. Then,bioguided
fractionationwas done on the crude extracts using Hexane,Methy-
lene Chloride andMethanol. Column chromatographywas done on
the methylene chloride fraction of the leaf ethanolic extract using
different solvent systems.
Results: The yields of extraction ranged from 1.125% to 6.77%
for the aqueous extract and from 3.57% to 10.67% for the ethanol
extracts. The phytochemical screening showed the presence of
phenols, tannins, ﬂavonoids and glycosides in both extracts. The
MIC ranged from 0.63±0.27 to 2.19±1.43mg/mL for the ethanol
extracts, from 1.88±0.00 to 7.50±0.00mg/mL for the aqueous
extract on the tested microorganisms. 35 fractions were obtained
after partition and their MIC results ranged from 1.25±0.00 to
≥10±0.00mg/mL on the tested microorganisms. Nineteen frac-
tions were obtained and labeled fraction A to fraction S with MIC
varying from 0.002 to ≥2mg/mL with fraction S having the best
activity.
Conclusion: The crude ethanol, aqueous extracts and fractions
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Background: In the United States, candidaemia is the fourth
most common nosocomial bloodstream infection. The crude
mortality ranges from 21%-59% and varies according to study pop-
ulation. Risk factors for mortality differ depending on species
distribution, severity of illness, antifungal treatment and age.
We aimed to determine factors associated with mortality among
patients with candidaemia in South Africa.
Methods & Materials: Patients with candidaemia were identi-
ﬁed through active laboratory-based surveillance at nine sentinel
hospitalsin 2012. An incident case of candidaemia was deﬁned
as the isolation of Candida species from the ﬁrst submitted
blood culture. Detailed clinical information was collected includ-
ing underlying diseases and in-hospital mortality. Identiﬁcation of
isolates and antifungal susceptibility testing was performed at a
reference laboratory. A multivariable logistic regression analysis,
stratiﬁed by age (neonates (≤ 30 days), children (>30 days and < 15
years) and adults (≥15 years)), was performed to determine factors
associated with mortality.
Results:Of548casesof candidaemia, 317hadaknownoutcome.
Adults, children and neonates accounted for 41% (130/317), 32%
(103/317) and 26% (84/317) respectively. Overall, Candida albicans
was the commonest species (50%), followed by Candida parapsilosis
(31%) and Candida glabrata (9%). The proportion of cases of C. para-
psilosis infectionwas lower in the older vs. younger age groups; the
opposite was true for C. glabrata. The overall crude mortality rate
was 46%.
Among neonates, presence of a predisposing condition (abdom-
inal surgery accounted for 70% (14/20))was signiﬁcantly associated
with death (OR 3.4, 95CI 1.06 -10.78, p =0.039) and receipt
of antifungal therapy was protective (OR 0.1 95CI 0.03-0.50,
p =0.004). Among children, intensive care unit (ICU) admission
was signiﬁcantly associated with death (OR 3.6 95CI 1.19-11.14,
p =0.023). Among adults, advanced agewas signiﬁcantly associated
with death (≥65 years: OR 16.1 95CI 2.52-102.48; 45-64 years: OR
9.0 95CI 1.70-47.38; 25-44 years: OR4.2 95CI 0.78-22.40 compared
to15-24 years, p =0.002) and receipt of antifungal treatment was
protective (OR 0.2 95CI 0.09-0.68, p =0.006).
Conclusion: Just under half of patients with culture-conﬁrmed
candidaemia died in hospital. Predictors of mortality differed by
age group and receipt of antifungal treatment was shown to be
protective among neonates and adults.
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